For Many Americans, Covid Is Still a Chronic, Disabling Disease. These Scientists Are Working Tirelessly to Bring Them Relief

Julia Moore Vogel, a computational biology and medicine expert with a PhD from Cornell University, had always been passionate about her work at Scripps Research in La Jolla, California. As a member of the National Institutes of Health's All of Us Research Program, Vogel helped gather health data from nearly 750,000 Americans to create potential treatments for devastating diseases.

Prior to the pandemic, she balanced a busy life with her husband, Bobby, and their young daughter, participating in outdoor activities and enjoying weekends at the park. However, the onset of the Covid-19 pandemic changed her life in an instant. Suffering from loss of taste and smell, followed by extreme fatigue, migraines, and difficulties concentrating, Vogel was diagnosed with long Covid in late August 2020.

Despite returning to work remotely from home initially, she found her symptoms intensified with physical exertion. By 2022, her condition had drastically reduced her mobility, forcing her to depend on a wheelchair for daily activities. Vogel's determination to understand her condition led her to study scientific papers and connect with other long Covid patients online.

As patients increasingly demanded recognition and treatment for their chronic symptoms, medical centers began to adopt more specialized approaches, experimenting with antivirals and immune regulators to alleviate the condition's symptoms. Despite no FDA-approved medications for long Covid, Vogel's boss, Dr. Eric Topol, invited her to contribute to a scientific literature review, allowing her to collaborate with patient-researchers Hannah Davis and Lisa McCorkell in shedding light on the elusive nature of this debilitating disease.